LONDON — A coronavirus vaccine developed by Pfizer and BioNTech appears to be effective against a key mutation in the more infectious variants of the virus discovered in the U.K. and South Africa, according to a study conducted by the U.S. pharmaceutical giant.It comes as countries scramble to contain the variants that are significantly more transmissible, with public health experts anxious about the potential impact on inoculation efforts.
looking good as UK rolling out massive vaccine program.
LONDON — A coronavirus vaccine developed by Pfizer and BioNTech...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.22 |
Change
-0.010(0.45%) |
Mkt cap ! $995.3M | |||
| Open | High | Low | Value | Volume |
| $2.22 | $2.25 | $2.19 | $2.365M | 1.063M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 223 | $2.22 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.24 | 4836 | 2 |
View Market Depth
| Last trade - 16.10pm 19/06/2025 (20 minute delay) ? |
| BVS (ASX) Chart |